CO BREATH ANALYSIS MODULE & MONOXOL II— 510(k) K952694
Substantially EquivalentBacharach, Inc.
FDA 510(k) clearance K952694 for CO BREATH ANALYSIS MODULE & MONOXOL II, Substantially Equivalent on 1996-01-29. Applicant: Bacharach, Inc..
Clearance details
- Applicant
- Bacharach, Inc.
- Product code
- Code CCJ
- Advisory panel
- Anesthesiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Bethesda, MD, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.